摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-hydroxy-2,5,7,8-tetramethyl-N-phenyl-3,4-dihydro-2H-1-benzopyran-2-carboxamide | 122003-39-8

中文名称
——
中文别名
——
英文名称
6-hydroxy-2,5,7,8-tetramethyl-N-phenyl-3,4-dihydro-2H-1-benzopyran-2-carboxamide
英文别名
N-Phenyl-(6-hydroxy-3,4-dihydro-2,5,7,8-tetramethyl-2H[1]-benzopyran-2-yl)carboxamide;N-phenyl-6-hydroxy-3,4-dihydro-2,5,7,8-tetramethyl-2H-1-benzopyran-2-carboxamide;6-hydroxy-2,5,7,8-tetramethyl-N-phenyl-3,4-dihydrochromene-2-carboxamide
6-hydroxy-2,5,7,8-tetramethyl-N-phenyl-3,4-dihydro-2H-1-benzopyran-2-carboxamide化学式
CAS
122003-39-8
化学式
C20H23NO3
mdl
——
分子量
325.408
InChiKey
CKXKDKUTMXBCOW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    24
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    58.6
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-溴甲基-7-氯喹啉6-hydroxy-2,5,7,8-tetramethyl-N-phenyl-3,4-dihydro-2H-1-benzopyran-2-carboxamidepotassium carbonatecaesium carbonate 、 sodium iodide 作用下, 以 丙酮 为溶剂, 反应 24.0h, 以67%的产率得到6-[(7-chloroquinolin-2-yl)methoxy]-2,5,7,8-tetramethyl-N-phenyl-3,4-dihydrochromene-2-carboxamide
    参考文献:
    名称:
    Synthesis and anti-inflammatory activity of N-(aza)arylcarboxamides derived from Trolox®
    摘要:
    A series of 6-(aza) arylmethoxychroman-2-carboxamides 22-38, derived from Trolox(R) or 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid, was prepared using two strategies, i.e. phenol blockade was carried out before or after amidification. These compounds were evaluated against peripheral inflammation by a carrageenin-induced foot-pad edema test. A permanent blockade of the phenol function by arylmethoxy groupings, in particular by the quinolylmethoxy moiety, was generally detrimental to activity; only the 6-benzyloxy and quinolylmethoxy derivatives 22 and 31 exhibited significant inhibition (58.3 and 97.1%) after oral administration of 0.4 mmol kg(-1). Among their 6-acetoxy or 6-hydroxy precursors 12-21, evaluated at 0.4 and 0.1 mmol kg(-1), the N-(4-pyridyl) chromancarboxamides 15 and 20 exerted the highest inhibitory activity. Their ID50 were 14.7 +/- 5.5 mg kg(-1) and 14.7 +/- 4.5 mg kg(-1), respectively. (C) Elsevier, Paris.
    DOI:
    10.1016/s0223-5234(98)80065-2
  • 作为产物:
    描述:
    N-Phenyl-(6-acetoxy-3,4-dihydro-2,5,7,8-tetramethyl-2H[1]-benzopyran-2-yl)carboxamide 在 sodium hydroxide 作用下, 以 乙醇 为溶剂, 反应 2.0h, 以86%的产率得到6-hydroxy-2,5,7,8-tetramethyl-N-phenyl-3,4-dihydro-2H-1-benzopyran-2-carboxamide
    参考文献:
    名称:
    Synthesis and anti-inflammatory activity of N-(aza)arylcarboxamides derived from Trolox®
    摘要:
    A series of 6-(aza) arylmethoxychroman-2-carboxamides 22-38, derived from Trolox(R) or 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid, was prepared using two strategies, i.e. phenol blockade was carried out before or after amidification. These compounds were evaluated against peripheral inflammation by a carrageenin-induced foot-pad edema test. A permanent blockade of the phenol function by arylmethoxy groupings, in particular by the quinolylmethoxy moiety, was generally detrimental to activity; only the 6-benzyloxy and quinolylmethoxy derivatives 22 and 31 exhibited significant inhibition (58.3 and 97.1%) after oral administration of 0.4 mmol kg(-1). Among their 6-acetoxy or 6-hydroxy precursors 12-21, evaluated at 0.4 and 0.1 mmol kg(-1), the N-(4-pyridyl) chromancarboxamides 15 and 20 exerted the highest inhibitory activity. Their ID50 were 14.7 +/- 5.5 mg kg(-1) and 14.7 +/- 4.5 mg kg(-1), respectively. (C) Elsevier, Paris.
    DOI:
    10.1016/s0223-5234(98)80065-2
点击查看最新优质反应信息

文献信息

  • Benzopyran compounds
    申请人:Adir et Compagnie
    公开号:US05393775A1
    公开(公告)日:1995-02-28
    A compound selected from those of formula (I): ##STR1## in which R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8, R.sub.9 and n are as defined in the description, its optical isomers, and its addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal product containing the same for treating a mammal afflicted with a disorder connected with peroxydation processes and biosynthesis of eicosanoids.
    从以下化学式(I)中选择的化合物:##STR1## 其中R.sub.1,R.sub.2,R.sub.3,R.sub.4,R.sub.5,R.sub.6,R.sub.7,R.sub.8,R.sub.9和n如描述中所定义,其光学异构体及其与药学上可接受的酸或碱形成的加合物盐,以及含有该化合物的药物产品,用于治疗患有与过氧化作用过程和前列腺素生物合成相关的疾病的哺乳动物。
  • New benzopyran compounds
    申请人:Adir et Compagnie
    公开号:US05395834A1
    公开(公告)日:1995-03-07
    A compound selected from those of formula (I): ##STR1## in which R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8, R.sub.9 and n are as defined in the description, its optical isomers, and its addition salts thereof with a pharmaceutically-acceptable acid or base, and medicinal product containing the same for treating a mammal afflicted with a disorder connected with peroxydation processes and biosynthesis of eicosanoids.
    从式(I)中选择的化合物:##STR1## 其中R.sub.1,R.sub.2,R.sub.3,R.sub.4,R.sub.5,R.sub.6,R.sub.7,R.sub.8,R.sub.9和n如说明书中所定义的,其光学异构体及其与药学上可接受的酸或碱的加合盐,以及含有该化合物的药物制剂,用于治疗患有与过氧化作用过程和Eicosanoids生物合成有关的哺乳动物的疾病。
  • Pharmaceutically active amines
    申请人:THE UPJOHN COMPANY
    公开号:EP0293078A1
    公开(公告)日:1988-11-30
    The aromatic amines (I), alkyl amines (II), bicyclic amines (III), cycloalkyl amines (IV), aromatic bicyclic amines (V), hydroquinone amines (VI), quinone amines (VII), amino-ethers (VIII) and bicyclic amino ethers (IX) are useful as pharmaceutical agents for treating a number of conditions including spinal trauma, mild and/or moderate to severe head injury, etc. Also dislosed is a method of treatment using the 3,4-dihydrobenzopyrans (XI).
    芳香胺 (I)、烷基胺 (II)、双环胺 (III) 环烷基胺 (IV)、芳香族双环胺 (V)、对苯二酚胺 (VI)、醌胺 (VII)、氨基醚 (VIII) 和双环氨基醚 (IX) 可用作治疗多种疾病的药物,包括脊柱创伤、轻度和/或中重度头部损伤等。此外,还公开了一种使用 3,4-二氢苯并吡喃(XI)的治疗方法。
  • Nouveaux composés benzopyraniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
    申请人:ADIR ET COMPAGNIE
    公开号:EP0512899A1
    公开(公告)日:1992-11-11
    Composés de formule I : dans laquelle R₁, R₂, R₃, R₄, R₅, R₆, R₇, X, et n sont définis dans la description,    leurs isomères optiques, et leurs sels d'addition à une base ou à un acide pharmaceutiquement acceptable. Médicaments.
    式 I 的化合物: 其中 R₁、R₂、R₃、R₄、R₅、R₆、R₇、X 和 n 如说明中所定义、 它们的光学异构体、 及其与药学上可接受的碱或酸的加成盐。 药物。
  • PHARMACEUTICALLY ACTIVE AMINES
    申请人:THE UPJOHN COMPANY
    公开号:EP0358676A1
    公开(公告)日:1990-03-21
查看更多